OB/Gyn Flashcards
1
Q
Dysfuncitonal Uterine Bleeding
A
- Presents as abnormal bleeding with a generally unremarkable PE
- Abnormal uterine bleeding in non-pregnant women
- different from normal cycle in terms of regularity, flow, duration, and volume
- normally occurs right after menarche or during perimenopause
- Causes = PALM-COIEN (polyp, adenomyosis, leiomyoma, malignancy - coag, ovulatory dysFN, endometrial, iatrogenic, not otherwise classified)
- Menorrhagia = heavy or prolonged bleeding
- Metrorrhagia = irregular bleeding between menses
- PE includes speculum, evaluate for bleeding from other sources
2
Q
Diagnostic studies for DUB
A
- B-hCG, CBC, iron, PT, PTT, documentation of ovulation, thyroid, serum P, LFTs, PRL, serum FSH
- Pap, US, hysterosalpingography, hysteroscopy, and/or D&C
- endometrial bx should be done on all women over 35yo w/ obesity, HTN, or DM and on all postmenopausal pts
3
Q
management of DUB (AUB)
A
- depends on severity of bleeding - may include observation, iron therapy, and volume replacement
- progestin trial - if bleeding stops, anovulatory cylces are confirmed
- OCPs:
- older women w/o risk factors
- OCPs should NOT be used in women over 35 who smoke, have HTN, DM, or hx of vascular dz, breast CA, liver dz, or focal HA
- D&C can be dx and curative
- refractory cases may require endometrial ablation or vaginal hysterectomy
4
Q
dysmenorrhea general characteristics
A
- PRIMARY: painful menstruation caused by increased prostaglandin and leukotriene levels - painful uterine cramping, N/V/D
- Onset: usually w/in 2yrs menarche, peak incidence = late teens/early 20s
- THERE IS NO PATHOLOGIC ABNORMALITY
- SECONDARY: painful menstruation caused by identifiable condition (usually uterus or pelvis - endometriosis, adenomyosis, fibroids, PID, IUD)
- usually affects older women (>25yo)
5
Q
clinical features of dysmenorrhea
A
- Primary: sxs are central lower abdomen or pelvis radiating to back or thighs, beginning before or at onset of menses, lasting 1-3 days
- PE, labs, radiologic tests = nl
- Secondary: similar sxs as above but may also include bloating, heavy menstrual bleeding, and dyspareunia
- less related to first day of flow
6
Q
diagnostic studies for dysmenorrhea
A
- dx of primary dysmenorrhea based on hx, use of menstrual diary, PE
- specific tests for secondary dysmenorrhea - hysteroscopy, D&C, laparoscopy
- all allow both dx and tx
7
Q
management of dysmenorrhea
A
- Primary:
- start NSAIDs right before expected menses, continue 2-3 days
- OCPs, vit B (B1, thiamine; B6, pyridoxine), magnesium, acupuncture, heat, regular exercise
- Secondary:
- underlying conditions should be treated
- sx treatment may be sufficient
8
Q
general characteristics of menopause
A
- definition: menopause is the last menses, and perimenopause (usually lasting 3-5 yrs) is the time surrounding menopause.
- Dx made: 1 yr of no periods after age 40 with no pathologic cause
- FSH elevated (21-100), estradiol low (<20)
- progesterone levels nl
- mean age = 51.5 yrs
- smoking is associated with early menopause
- premautre menopause (spontanous premature ovarian failure) is cessation of menses before age 40 years
- ovaries continue to produce testosterone and androstenedione; estrone is the predominant postmenopausal circulating estrogen
9
Q
clinical features of menopause
A
- vasomotor sxs (hot flashes) vary in intensity - usually resolve in 2-3 yrs (3-6 wks with E tx)
- urogenital atrophy can cause poor vaginal lubrication, dyspareunia, dysuria, urge incontinence, pelvic relaxation, atrophic cystitis, easy bleeding
- accelerated bone loss may cause osteoporosis
- E related cardiovascular protection declines
- changes in sleep cycle
- skin thins, becomes less elastic, facial hair increases, hair loss increases and nails become brittle
- confusion, memory loss, lethargy, depression, loss of sex interest
10
Q
diagnostic studies for menopause
A
- FSH of greater than 30 is diagnostic of menopause
11
Q
management of menopause
A
- treated on the basis of individual risk factors and sxs
- lifestyle modifications may help sxs, reg exercise can decrease menopausal sxs
- women with INTACT uterus should NOT use E alone (increased risk of endometrial CA)
- combined hormone replacement tx indicated for short-term tx of hot flashes
- can increase risk of CV dz, breast CA, and cognitive changes
- contraindications to hormone tx include undiagnosed vaginal bleeding, acute vascular thrombosis, liver dz, hx of endometrial or breast CA
- Ca and vit D supplementation, bisphosphonates, SERMs, calcitonin all used for osteoporosis
- topical E can improve urogenital sxs
- SSRI and SNRIs (caution with use with tamoxifen)
- soy, black cohosh, and ginseng may also help alleviate sxs
12
Q
Cervical carcinoma etiology, RF, sxs, dx, tx
A
- bimodal distribution (35-39; 60-64)
- RF: HPV exposure, early coitarche, multiple sex partners, immunosuppression, SMOKING, low SE status, lack of reg pap smears
- sxs: postcoital bleeding, vaginal bleeding and d/c, dyspareunia
- dx: abnormal cytology, HPV (+), gross lesion
- tx:
- stage 1: conservative, simple, or radical hysterectomy
- stage 2 +: chemo +/- radiation
13
Q
cervical dysplasia
A
- MCC: HPV 16 and 18 (18 MC with adenocarcinoma)
- Most HPV infxns regress in 2 yrs
- HPV not enough to cause cancer itself - requires cofacts (smoking, hormones, OCP (>5y), dietary, immunosuppression (lupus), HIV)
- RF: old, AA, low ES, low edu, increased # sex partners, SMOKING, multiparous,, hx of STD
- Indications for conization (LEEP or cold knife):
- unsatisfactory colpo
- +endocerv curettage
- Pap smear indicating adenocarcinoma in situ
- bx that cannot rule out invasive CA
- Discrepancy between pap smear and bx result
14
Q
cervical cytology results and recommended next steps
A
- ASCUS (atypical squamous cells of undetermined significance)
- repeat cytology at 6-12 mo
- if both negative, return to routine screening
- if either +, colposcopy
- repeat cytology at 6-12 mo
- AGC (atypical glandular cells of undetermined significance)
- colposcopy with bx of lesions
- LSIL (low-grade intraepithelial lesions)
- colposcopy with bx of lesions
- HSIL (high-grade intraepithelial lesions)
- colposcopy with bx of lesions
15
Q
Breast cancer RF
A
- age, sex, first degree relative, BRCA1 or 2
- associated factors: nulliparity, ealry menarche, late menopause, post men ERT or radiation exposure, advanced maternal age at first term birth
- ALL invasive lobular and 2/3 ductal carcinomas are HER2 pos (estrogen-receptor)
16
Q
Breast CA presentation
A
- single, nontender, firm, immobile mass
- 45% upper outer quadrant, 25% under nipple and areola
- signs: early, no palpable masses
- rare: nipple d/c, retraction, dimpling, breast enlargement, shrinkage, skin thickening or peau d’orange, eczematous changes, breast pain, fixed mass, axillary node enlargement, ulcerations, arm edema, palpable supraclavicular nodes
17
Q
Breast CA dx, tx
A
- dx: any solid dominant breast mass on exam evaluated with FNA or excisional bx
- genetic testing for pts with strong family hx
- axillary lymph node staging with sentinel lymph node bx
- tx: tamoxifen: for estrogen receptor pos dz and postmen women
- adjuvant chemo and hormonal manipulaiton
- lumpectomy with sentinel node bx preferred for early stage
- breast cancer associated with higher risk of endometrial cancer and vice-versa
- axillary lymph node status is the most important prognostic factor for invasive carcinoma in the absence of distant metastasis